Does Your Skin Cancer Type — Decide the Treatment?

For most basal cell carcinomas, yes, surgery to remove the growth is the usual first treatment, and it is often the only treatment you need. Basal cell carcinoma grows slowly and almost never spreads elsewhere on the body, which is why doctors don't usually reach for radiation or immunotherapy unless surgery isn't a safe or practical option for you. If the spot is in a place that is hard to operate on, such as close to your eye or nose, or if you have another health condition that makes anaesthesia risky, your doctor may suggest radiation instead. Either way, ask your team to explain why they chose the approach they did for your specific spot.

Yes, radiation can be used instead of surgery for squamous cell carcinoma, though surgery remains the usual first choice for most people. Doctors consider radiation when the growth sits somewhere surgery would leave a difficult scar or affect how a nearby body part works, such as the lip or ear, or when a patient's age or overall health makes anaesthesia risky. Radiation removes the cancer over several visits rather than one procedure. Your team will weigh the exact size, depth and location of your growth, along with your general health, before recommending which approach suits you better.

Not necessarily a cause for worry. Many people with early, shallow melanoma need only surgery, and immunotherapy never comes into the conversation for them. Immunotherapy is usually discussed once melanoma has grown deeper into the skin or reached a lymph node. If your report doesn't mention it, your melanoma may fall into the earlier group where surgery alone is the standard approach. Every melanoma report is reviewed against how deep and how far the growth has gone, so ask your doctor directly what your own report shows and why immunotherapy has or hasn't come up for your case.

Not always, but it becomes part of the conversation far more often once melanoma has grown deeper into the skin or reached a lymph node. Your tumour board looks at how deep the melanoma has grown, whether it has reached a lymph node, and your overall health before deciding whether immunotherapy adds real benefit for you. Some people with deeper melanoma still do well with surgery alone. Immunotherapy is offered when there's a meaningful chance that cells have travelled beyond what surgery removed, not automatically for every deeper melanoma. Ask your team what specifically about your report led to their recommendation.

Because basal cell carcinoma and melanoma behave very differently, even though both are called skin cancer. Basal cell carcinoma grows slowly in one place and almost never spreads, so removing it with surgery usually finishes the treatment. Melanoma can send cells into the bloodstream or a lymph node earlier and more often, especially once it has grown past the skin's surface. That difference, not the seriousness of your relative's case compared to yours, is why your paths look different. Comparing two skin cancer diagnoses by treatment alone can be misleading. What matters is what your own type, and your own report, actually show.

It's uncommon, but not impossible. Basal cell and squamous cell cancers almost always stay in one place and are cured with surgery or radiation. In rare cases where either type has grown very large, come back after earlier treatment, or spread beyond the skin, immunotherapy or another drug treatment may be considered. This is far less common than it is for melanoma, where deeper or spread disease brings immunotherapy into the discussion much more often. If your doctor has raised immunotherapy for a basal cell or squamous cell cancer, ask what makes your case different from the usual early-stage picture.